Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top

memo - Magazine of European Medical Oncology

Issue 2/2016

Content (11 Articles)

editorial

memo—new frontiers to be reached

Wolfgang Hilbe, Waltraud Radlherr

case report

Intravascular large B‑cell lymphoma

Silvia Hofer, Manfred Kessler, Jeanne Godau, Daniela Weiler, Karl Frontzek, Elisabeth Jane Rushing, Stefan Aebi

Open Access case report

Long-term treatment of hairy cell leukemia with interferon-α: still a viable therapeutic option

Jan-Paul Bohn, Guenther Gastl, Michael Steurer

Open Access short review

Immunotherapy for head and neck squamous cell carcinoma

Thorsten Fuereder

original report

Association of TP53 mutations with TP53 codon 72 polymorphism and outcome in triple-negative breast cancer

Mathilde Foedermayr, Miriam Sebesta, Margaretha Rudas, Anna S. Berghoff, Regina Promberger, Matthias Preusser, Peter Dubsky, Michael Gnant, Guenther G. Steger, Ansgar Weltermann, Christoph C. Zielinski, Otto Zach, Rupert Bartsch

Open Access short review

CDK4/6 inhibition in luminal breast cancer

Simon Peter Gampenrieder, Gabriel Rinnerthaler, Richard Greil

Open Access short review

Immune checkpoint blockade in ovarian cancer

Lukas Weiss, Florian Huemer, Brigitte Mlineritsch, Richard Greil

case report

Endometrial cancer treated with levonorgestrel-releasing intrauterine device for almost three years in an elderly woman with comorbidity

Lisbeth Anita Andreasen, Sofie Leisby Antonsen, Annette Settnes

short review

Circulating tumor cells and circulating tumor DNA in colon cancer

Mikhail Fedyanin, Elizaveta Polyanskaya, Sergei Tjulandin

comment

Is there room for chemotherapy in elderly patients with metastatic castration-resistant prostate cancer (mCRPC) in the era of targeted hormone therapy?

Ercan Müldür

review

Initial emergencies in children and adolescents with malignant hematologic–oncological diseases

Andishe Attarbaschi, Georg Mann

Mar 16
Issue: Special Issue 2/2016
Report from the ESMO Asia 2015 Congress, Singapore, 18th–21st December, 2015
Jul 16
Issue: Special Issue 3/2016
Report from the ASCO 2016 Congress, Chicago, 3rd-7th June, 2016

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits